Ablavar (gadofosveset) is a small molecule pharmaceutical. Gadofosveset was first approved as Ablavar on 2008-12-22.
Trade Name |
Ablavar |
Common Name |
Gadofosveset |
Indication |
|
Drug Class |
Phosphoro-derivatives; gadolinium derivatives (principally for diagnostic use) |